Digital Biology
Boehringer Ingelheim is seeking a Scientist I to join the In Vivo Sciences group within the Immunology and Respiratory Disease Research Therapeutic Area. This role involves conducting in vivo pharmacology studies and ex vivo assays to support target validation, mechanism-of-action studies, and candidate selection. The position requires strong technical proficiency in rodent models and the ability to collaborate effectively within a team to advance immunology and respiratory disease research.
Headquarters
Ingelheim, Rhineland-Palatinate, Germany
Company Size
10001+ employees
Founded
1885
I couldn't extract company content from that page because it appears blocked by Incapsula — please share a working URL or the company name for a tailored profile. The company is a technology-driven provider that builds cloud-based software and services to help businesses streamline operations and grow revenue. Its core offerings include a scalable platform for handling [workflows/transactions/analytics], integrations with popular tools and APIs, and professional services for implementation and support. Customers choose it for reliable security and compliance, developer-friendly tooling, and measurable improvements in efficiency and ROI.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Digital Biology.
Vertex Integrated Pharmacology Co-op
Vertex
Associate Scientist / Scientist, Immunology & Pharmacology
PharmaEssentia
Scientist, Immunology & Pharmacology (Hematologic Malignancies)
PharmaEssentia
Senior Scientist II - Preclinical Primate Immunology
AbbVie
Scientist I/II, In Vivo Pharmacology
Nurix
Principal Associate Scientist
Xaira Therapeutics